These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

717 related articles for article (PubMed ID: 15542806)

  • 1. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain magnetic resonance imaging after high-dose chemotherapy and radiotherapy for childhood brain tumors.
    Spreafico F; Gandola L; Marchianò A; Simonetti F; Poggi G; Adduci A; Clerici CA; Luksch R; Biassoni V; Meazza C; Catania S; Terenziani M; Musumeci R; Fossati-Bellani F; Massimino M
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(4):1011-9. PubMed ID: 17904307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose chemotherapy and autologous hematopoietic progenitor cell rescue in children with recurrent medulloblastoma and supratentorial primitive neuroectodermal tumors: the impact of prior radiotherapy on outcome.
    Butturini AM; Jacob M; Aguajo J; Vander-Walde NA; Villablanca J; Jubran R; Erdreich-Epstein A; Marachelian A; Dhall G; Finlay JL
    Cancer; 2009 Jul; 115(13):2956-63. PubMed ID: 19402050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors.
    Reddick WE; White HA; Glass JO; Wheeler GC; Thompson SJ; Gajjar A; Leigh L; Mulhern RK
    Cancer; 2003 May; 97(10):2512-9. PubMed ID: 12733151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma.
    Mulhern RK; Palmer SL; Merchant TE; Wallace D; Kocak M; Brouwers P; Krull K; Chintagumpala M; Stargatt R; Ashley DM; Tyc VL; Kun L; Boyett J; Gajjar A
    J Clin Oncol; 2005 Aug; 23(24):5511-9. PubMed ID: 16110011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK; Rood B; Kamani N; Lafond D; Perez-Albuerne E; Loechelt B; Packer RJ; MacDonald TJ
    Pediatr Blood Cancer; 2007 Mar; 48(3):278-84. PubMed ID: 16456857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F; Baumert BG; Creak AL; Warrington AP; Ashley S; Traish D; Brada M
    Pediatr Blood Cancer; 2008 Mar; 50(3):554-60. PubMed ID: 17941071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemotherapy and reduced-dose cranial spinal irradiation followed by conformal posterior fossa tumor bed boost for average-risk medulloblastoma: efficacy and patterns of failure.
    Douglas JG; Barker JL; Ellenbogen RG; Geyer JR
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1161-4. PubMed ID: 15001259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose craniospinal irradiation and ifosfamide, cisplatin and etoposide for non-metastatic embryonal tumors in the central nervous system.
    Yasuda K; Taguchi H; Sawamura Y; Ikeda J; Aoyama H; Fujieda K; Ishii N; Kashiwamura M; Iwasaki Y; Shirato H
    Jpn J Clin Oncol; 2008 Jul; 38(7):486-92. PubMed ID: 18573848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intracranial cerebrospinal fluid cytology in staging pediatric medulloblastomas, supratentorial primitive neuroectodermal tumors, and ependymomas.
    Terterov S; Krieger MD; Bowen I; McComb JG
    J Neurosurg Pediatr; 2010 Aug; 6(2):131-6. PubMed ID: 20672933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone suppression for protection against hypothyroidism due to craniospinal irradiation for childhood medulloblastoma/primitive neuroectodermal tumor.
    Massimino M; Gandola L; Collini P; Seregni E; Marchianò A; Serra A; Pignoli E; Spreafico F; Pallotti F; Terenziani M; Biassoni V; Bombardieri E; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):404-10. PubMed ID: 17601681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracerebral cavernous hemangioma after cranial irradiation in childhood. Incidence and risk factors.
    Strenger V; Sovinz P; Lackner H; Dornbusch HJ; Lingitz H; Eder HG; Moser A; Urban C
    Strahlenther Onkol; 2008 May; 184(5):276-80. PubMed ID: 18427759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.
    Jimenez RB; Sethi R; Depauw N; Pulsifer MB; Adams J; McBride SM; Ebb D; Fullerton BC; Tarbell NJ; Yock TI; Macdonald SM
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):120-6. PubMed ID: 23790826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of dietetic intervention in children with medulloblastoma or supratentorial primitive neuroectodermal tumors.
    Bakish J; Hargrave D; Tariq N; Laperriere N; Rutka JT; Bouffet E
    Cancer; 2003 Sep; 98(5):1014-20. PubMed ID: 12942570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors influencing neurocognitive outcomes in young patients with benign and low-grade brain tumors treated with stereotactic conformal radiotherapy.
    Jalali R; Mallick I; Dutta D; Goswami S; Gupta T; Munshi A; Deshpande D; Sarin R
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(4):974-9. PubMed ID: 19864079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vertebral body growth after craniospinal irradiation.
    Hartley KA; Li C; Laningham FH; Krasin MJ; Xiong X; Merchant TE
    Int J Radiat Oncol Biol Phys; 2008 Apr; 70(5):1343-9. PubMed ID: 18164830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma.
    Jakacki RI; Feldman H; Jamison C; Boaz JC; Luerssen TG; Timmerman R
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):531-6. PubMed ID: 15380589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Online quality control, hyperfractionated radiotherapy alone and reduced boost volume for standard risk medulloblastoma: long-term results of MSFOP 98.
    Carrie C; Grill J; Figarella-Branger D; Bernier V; Padovani L; Habrand JL; Benhassel M; Mege M; Mahé M; Quetin P; Maire JP; Baron MH; Clavere P; Chapet S; Maingon P; Alapetite C; Claude L; Laprie A; Dussart S
    J Clin Oncol; 2009 Apr; 27(11):1879-83. PubMed ID: 19273707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in supratentorial damage of white matter in pediatric survivors of posterior fossa tumors with and without adjuvant treatment as detected by magnetic resonance diffusion tensor imaging.
    Rueckriegel SM; Driever PH; Blankenburg F; Lüdemann L; Henze G; Bruhn H
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):859-66. PubMed ID: 19540067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M; Gandola L; Spreafico F; Luksch R; Collini P; Giangaspero F; Simonetti F; Casanova M; Cefalo G; Pignoli E; Ferrari A; Terenziani M; Podda M; Meazza C; Polastri D; Poggi G; Ravagnani F; Fossati-Bellani F
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1031-7. PubMed ID: 16343801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.